European Shares May See Soft Opening
RTTNews) - European stocks may open on a sluggish note Wednesday as investors react to mixed earnings results from U.S.
All posts by RTTNews
Read More »
RTTNews
09:19
Standard Chartered Q3 Pre-tax Profit Surges; Lifts FY Operating Income View, Distribution Target
RTTNews) - British lending major Standard Chartered Plc (SCBFF.PK, STAC.L, STAN.L) reported Wednesday significantly higher profit before tax in its
RTTNews
14:20
Videndum CEO Stephen Bird Steps Down; Names Stephen Harris Executive Chairman
RTTNews) - Videndum Plc (VID.L), the international provider of premium branded hardware products and software solutions to the growing content
RTTNews
09:22
Holcim Q3 Recurring EBIT Rises, Sales Down; Confirms FY24 Outlook
RTTNews) - Swiss building materials firm Holcim Group (HCMLY.PK, HCMLF.PK) reported Friday that its third-quarter recurring EBIT grew 4.6 percent
RTTNews
09:22
SGS Q3 Sales Rises; Confirms FY24 Outlook
RTTNews) - SGS Group (SGSOY.PK), a Swiss inspection, verification, testing and certification company, reported Friday that its third-quarter sales increased
RTTNews
10:44
Sensex, Nifty Modestly Higher In Early Trade
RTTNews) - Indian shares were slightly higher on Tuesday despite weak cues from global markets due to lingering Middle East
RTTNews
13:26
Sanofi Enters Exclusive Negotiations To Sell 50% Stake In Opella To CD&R
RTTNews) - Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its
RTTNews
11:26
Nurix Reports Positive Results For BTK Degrader NX-5948 In Waldenstrom’s Macroglobulinemia
RTTNews) - Nurix Therapeutics Inc. (NRIX) presented positive clinical data from its ongoing Phase 1a/1b clinical trial of NX-5948, an
RTTNews
13:28
Asian Shares Decline Amid Tech Selloff
RTTNews) - Asian stocks fell broadly on Wednesday due to lingering Middle East tensions, shifting U.S. rate cut expectations and
RTTNews
16:24
Bayer Submits Application To EMA For Third Indication Of Darolutamide
RTTNews) - Bayer announced the submission of an application to the European Medicines Agency for the oral androgen receptor inhibitor
